Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database
In 273 770 individuals with ASCVD, higher lipoprotein(a) levels were associated with continuously increasing risk of recurrent ASCVD events regardless of sex and race/ethnicity that may have been partially mitigated by high impact LDL cholesterol-lowering therapy.
Authors
- Theresa Stern
- Katherine Wilemon (ORCID: https://orcid.org/0000-0003-4629-6866)
- Joshua W. Knowles (ORCID: https://orcid.org/0000-0003-1922-7240)
- Diane MacDougall (ORCID: https://orcid.org/0009-0004-7332-4185)
- Mary P. McGowan (ORCID: https://orcid.org/0000-0001-5761-9267)
- Børge Grønne Nordestgaard (ORCID: https://orcid.org/0000-0002-1954-7220)
- Seth J. Baum (ORCID: https://orcid.org/0000-0003-1202-8126)
- Anne Tybjærg-Hansen
- Bonnie Hartsuff
Institutions
- University of Copenhagen (DK)
- Cardiovascular Institute of the South (US)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Heart Foundation (US)
- Stanford University (US)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1093/eurheartj/ehaf297
- Citations
- 19
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 38.12
Funders
- Hartstichting